Plandaí Biotechnology reported that Azochem Laboratories, a contract manufacturer for USN in South Africa, placed the second USN related purchase order for the company's Phytofare Catechin Complex The exclusive agreement between Plandai and USN will allow USN to control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts it now uses in its lineup of products, with the clinically proven highly bio available Phytofare Catechin Complex.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0004 USD | -.--% | -20.00% | +100.00% |
2023 | Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC. | CI |
2023 | Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc | CI |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 3.56M | |
+180.51% | 8.67B | |
+2.29% | 983M | |
+41.91% | 883M | |
+26.17% | 825M | |
+1.92% | 665M | |
+9.52% | 664M | |
-.--% | 600M | |
+9.17% | 530M | |
-.--% | 500M |
- Stock Market
- Equities
- PLPL Stock
- News Plandaí Biotechnology, Inc.
- Plandai Biotechnology to Deliver Green Tea Extract to USN